Multiplex Assays Market 2022-2026: An Overview To The Future Opportunities Over The Global

1
MarketsandMarkets Presents
Multiplex Assays Market worth 4.3 billion by 2026
https//www.marketsandmarkets.com/Market-Reports/m
ultiplex-assays-market-61593314.html
2

• The report "Multiplex Assays Market by product
  (Consumables, Instruments, Software Services),
  Type (Nucleic Acid, Protein, Cell), Technology
  (Flow Cytometry, Luminescence, Application (RD,
  Diagnosis), End User (Pharma Biotech, Hospital)
  - Global Forecast to 2026", is projected to reach
  USD 4.3 billion by 2026 from USD 3.0 billion in
  2021, at a CAGR of 7.6 during the forecast
  period.
• The increasing adoption of companion diagnostics
  and the rising need for effective analytical
  platforms in research and clinical diagnostics to
  reduce the operational costs and the time taken
  for diagnosis are the major factors driving the
  market growth.
• Product and Service accounted for the largest
  share of the multiplex assays market and is
  expected to grow at the highest CAGR
• Protein-based multiplex assays segment is
  expected to account for the largest share of the
  global multiplex assays market and is expected to
  grow at the highest CAGR
• Flow cytometry segment is expected to account for
  the largest share of the global multiplex assays
  market and is expected to grow at the highest
  CAGR
• Download a PDF Brochure https//www.marketsandmar
  kets.com/pdfdownload

3

• Objectives of the Study
• To define, describe, and forecast the global
  multiplex assays market based on the product
  service, type, technology, application, end user,
  and region
• To provide detailed information regarding the
  major factors influencing the growth of the
  market (such as drivers, restraints,
  opportunities, and challenges)
• To strategically analyse micromarkets with
  respect to individual growth trends, prospects,
  and contributions to the overall multiplex assays
  market
• To analyse opportunities in the market for
  stakeholders and provide details of the
  competitive landscape for market leaders
• To forecast the size of the market segments with
  respect to five main regions, namely, North
  America, Europe, Asia Pacific, and the Rest of
  the World
• To strategically profile the key players and
  comprehensively analyse their product portfolios,
  market positions, and core competencies
• To track and analyse competitive developments
  such as acquisitions, product launches,
  expansions, agreements, partnerships, and RD
  activities in the multiplex assays market.
• Speak to Analyst https//www.marketsandmarkets.co
  m/speaktoanalyst

4
This report categorizes the multiplex assays
market into the following segments and
subsegments

• By Product and Service
• Consumables
• Instruments
• Software and Services
• By Type
• Protein Multiplex Assays
• Nucleic Acid Multiplex Assays
• Cell-Based Multiplex Assays
• By Technology
• Flow Cytometry
• Fluorescence Detection
• Luminescence
• Multiplex Real-Time PCR
• Other Technologies
• By Application
• Research Development

5

Luminex Corporation (US), Thermo Fisher
Scientific Inc. (US), Illumina, Inc (US), Bio-Rad
Laboratories, Inc. (US), Qiagen N.V.
(Netherlands), Abcam plc (UK), Becton, Dickinson
and Company (US), Merck KGaA (Germany), Agilent
Technologies, Inc. (US), Meso Scale Diagnostics
(US), Randox Laboratories (UK), Quanterix (US),
Bio-Techne Corporation (US), Olink (Sweden),
DiaSorin S.p.A. (Italy), Seegene (South Korea),
Promega Corporation (US), Siemens Healthineers
(Germany), PerkinElmer, Inc. (US), Shimadzu
Biotech (Japan), Antigenix America, Inc. (US),
Enzo Life Sciences, Inc. (US), Boster Biological
Technology (US), AYOXXA Biosystems GmbH
(Germany), and Cayman Chemical Company (US).
6
Company Insights
Illumina, Inc. (US) is one of the leading players
in the Multiplex Assays Market. The company has a
strong geographic presence across the US, Europe,
Greater China, and the Asia Pacific. The company
focuses on offering consumables and analyzers in
the multiplex assays market. Illumina
concentrates on inorganic strategies to maintain
its leadership position in this market. The
company has signed several collaborations and
partnerships with other companies/organizations,
which are expected to strengthen the foothold of
the company in the domain of next-generation
sequencing (NGS) and multiplex sequencing. Lumine
x Corporation (US) is one of the leading players
in the Multiplex Assays Market. Luminex focuses
on product launches and developments to enhance
its position in the market. The company has the
EUA by the US FDA for multiplex COVID-19
assays. Bio-Rad Laboratories, Inc. (US) is one
of the leading players in the Multiplex Assays
Market. The company has a wide geographical
presence in the US, Singapore, China, the UK,
Belgium, Switzerland, France, and Germany. The
company has a strong RD and manufacturing in the
area of specialty chemicals and clinical
diagnostics. The company has received the EUA
from the US FDA for several COVID-19 multiplex
assays.
7
About MarketsandMarkets
MarketsandMarkets provides quantified B2B
research on 30,000 high growth niche
opportunities/threats which will impact 70 to
80 of worldwide companies revenues. Currently
servicing 5000 customers worldwide including 80
of global Fortune 1000 companies as clients.
Almost 75,000 top officers across eight
industries worldwide approach MarketsandMarkets
for their painpoints around revenues
decisions. Our 850 fulltime analyst and SMEs at
MarketsandMarkets are tracking global high
growth markets following the "Growth Engagement
Model GEM". The GEM aims at proactive
collaboration with the clients to identify new
opportunities, identify most important customers,
write "Attack, avoid and defend" strategies,
identify sources of incremental revenues for both
the company and its competitors.
MarketsandMarkets now coming up with 1,500
MicroQuadrants (Positioning top players across
leaders, emerging companies, innovators,
strategic players) annually in high growth
emerging segments. MarketsandMarkets is
determined to benefit more than 10,000 companies
this year for their revenue planning and help
them take their innovations/disruptions early to
the market by providing them research ahead of
the curve. MarketsandMarketss flagship
competitive intelligence and market research
platform, "RT" connects over 200,000 markets and
entire value chains for deeper understanding of
the unmet insights along with market sizing and
forecasts of niche markets.
8
Contact Us
ContactMr. Aashish MehraMarketsandMarkets
INC. 630 Dundee Road, Suite 430 Northbrook, IL
60062 USA 1-888-600-6441 sales_at_marketsandmarkets.
com Press release https//www.marketsandmarkets.
com/PressReleases/multiplex-assays.asp Research
insights https//www.marketsandmarkets.com/Resear
chInsight/multiplex-assays-market.asp